000 | 01289 a2200373 4500 | ||
---|---|---|---|
005 | 20250513150143.0 | ||
264 | 0 | _c19980922 | |
008 | 199809s 0 0 eng d | ||
022 | _a1042-8194 | ||
024 | 7 |
_a10.3109/10428199809068569 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMyers, D E | |
245 | 0 | 0 |
_aLarge scale manufacturing of B43(anti-CD19)-genistein for clinical trials in leukemia and lymphoma. _h[electronic resource] |
260 |
_bLeukemia & lymphoma _cApr 1998 |
||
300 |
_a329-38 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAntibodies, Monoclonal |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aGenistein _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoconjugates _xchemistry |
650 | 0 | 4 |
_aLeukemia _xtherapy |
650 | 0 | 4 |
_aLymphoma _xtherapy |
650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
700 | 1 | _aSicheneder, A | |
700 | 1 | _aClementson, D | |
700 | 1 | _aDvorak, N | |
700 | 1 | _aVenkatachalam, T | |
700 | 1 | _aSev, A R | |
700 | 1 | _aChandan-Langlie, M | |
700 | 1 | _aUckun, F M | |
773 | 0 |
_tLeukemia & lymphoma _gvol. 29 _gno. 3-4 _gp. 329-38 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428199809068569 _zAvailable from publisher's website |
999 |
_c9650657 _d9650657 |